Guy Caljon

Wilrijk, VLG 2610, Belgium

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 172 publications

A strategic discovery roadmap towards high-quality leads and drug development candidates for kinetoplastid diseases. Part 3: from lead towards a drug development candidate.

A strategic discovery roadmap towards high-quality leads and drug development candidates for kinetoplastid diseases. Part 3: from lead towards a drug development candidate.

Journal: The Journal of antimicrobial chemotherapy
Published: May 11, 2026

A strategic discovery roadmap towards high-quality leads and drug development candidates for kinetoplastid diseases. Part 1: setting the stage.

A strategic discovery roadmap towards high-quality leads and drug development candidates for kinetoplastid diseases. Part 1: setting the stage.

Journal: The Journal of antimicrobial chemotherapy
Published: May 05, 2026

5‑Nitrofuran-Semicarbazone Hybrids as Antitrypanosomal Agents: Structure-Activity Relationship and Nitroreductase Activation.

5‑Nitrofuran-Semicarbazone Hybrids as Antitrypanosomal Agents: Structure-Activity Relationship and Nitroreductase Activation.

Journal: ACS medicinal chemistry letters
Published: April 13, 2026

Late-Stage Diversification of Rewired Purine C-Nucleosides Reveals Potent Antitrypanosomatid Agents with In Vivo Efficacy.

Late-Stage Diversification of Rewired Purine C-Nucleosides Reveals Potent Antitrypanosomatid Agents with In Vivo Efficacy.

Journal: Journal of medicinal chemistry
Published: April 03, 2026

A strategic discovery roadmap towards high-quality leads and drug development candidates for kinetoplastid diseases. Part 2: from molecule to confirmed hit.

A strategic discovery roadmap towards high-quality leads and drug development candidates for kinetoplastid diseases. Part 2: from molecule to confirmed hit.

Journal: The Journal of antimicrobial chemotherapy
Published: March 31, 2026

Multifaceted biological and computational assessment of aromatic and N-heteroaromatic non-substituted thiosemicarbazones.

Multifaceted biological and computational assessment of aromatic and N-heteroaromatic non-substituted thiosemicarbazones.

Journal: Scientific reports
Published: January 14, 2026

The EamA metabolite transporter does not affect antileishmanial drug susceptibility.

The EamA metabolite transporter does not affect antileishmanial drug susceptibility.

Journal: International journal for parasitology. Drugs and drug resistance
Published: November 12, 2025

Selective and Orally Bioavailable Dipeptidyl Peptidase 9 Inhibitors with Potent Pyroptosis Induction Properties.

Selective and Orally Bioavailable Dipeptidyl Peptidase 9 Inhibitors with Potent Pyroptosis Induction Properties.

Journal: Journal of medicinal chemistry
Published: October 29, 2025

Cytotoxicity and Antimicrobial Activity of GaMF1 Analogs.

Cytotoxicity and Antimicrobial Activity of GaMF1 Analogs.

Journal: ChemMedChem
Published: October 22, 2025

Sustainable Antiparasitic Agents from an Agro-Industrial Waste: Mitochondria-Targeting Cashew Nutshell Liquid-Derived Phosphonium and Ammonium Salts.

Sustainable Antiparasitic Agents from an Agro-Industrial Waste: Mitochondria-Targeting Cashew Nutshell Liquid-Derived Phosphonium and Ammonium Salts.

Journal: Journal of medicinal chemistry
Published: September 08, 2025

Collaborative Synthesis for Neglected Diseases through the Open Synthesis Network: Structure-Activity Relationships of Arylaminopyrazoles as Chagas Disease Treatments.

Collaborative Synthesis for Neglected Diseases through the Open Synthesis Network: Structure-Activity Relationships of Arylaminopyrazoles as Chagas Disease Treatments.

Journal: ACS infectious diseases
Published: August 11, 2025

Thiazolidinones and related analogues as efficient antitrypanosomal agents.

Thiazolidinones and related analogues as efficient antitrypanosomal agents.

Journal: Bioorganic & medicinal chemistry
Published: July 04, 2025
Showing 1-12 of 172

Last Updated: 09/26/2026